Avadel Pharmaceuticals's market cap is currently $822.93M. The company's EPS TTM is $-0.772; its P/E ratio is ―; Avadel Pharmaceuticals is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 27.96M	$ 0.00	$ 0.00	$ 22.33M	$ 59.22M
Gross Profit	$ 27.12M	$ -1.49M	$ -815.00K	$ 16.59M	$ 47.09M
Operating Income	$ -137.85M	$ -98.56M	$ -85.55M	$ -36.66M	$ -16.83M
EBITDA	$ -149.13M	$ -97.60M	$ -84.78M	$ -34.97M	$ -23.61M
Net Income	$ -160.28M	$ -137.46M	$ -77.33M	$ 7.03M	$ -33.23M
Balance Sheet
Cash & Short-Term Investments	$ 105.11M	$ 96.50M	$ 157.22M	$ 221.40M	$ 64.16M
Total Assets	$ 164.70M	$ 132.78M	$ 247.26M	$ 311.64M	$ 151.44M
Total Debt	$ 35.38M	$ 131.02M	$ 145.00M	$ 130.52M	$ 124.65M
Net Debt	$ 4.22M	$ 57.04M	$ 94.30M	$ 58.80M	$ 114.88M
Total Liabilities	$ 76.96M	$ 153.93M	$ 169.02M	$ 149.37M	$ 180.63M
Stockholders' Equity	$ 87.74M	$ -21.14M	$ 78.24M	$ 162.27M	$ -29.20M
Cash Flow
Free Cash Flow	$ -128.51M	$ -71.02M	$ -77.34M	$ -48.83M	$ -38.35M
Operating Cash Flow	$ -128.51M	$ -70.30M	$ -77.31M	$ -48.73M	$ -38.33M
Investing Cash Flow	$ -50.09M	$ 79.70M	$ 56.93M	$ -69.72M	$ 38.72M
Financing Cash Flow	$ 135.34M	$ 14.54M	$ 263.00K	$ 179.68M	$ -27.00K

Currency in USD

Avadel Pharmaceuticals Earnings and Revenue History

Income Statement >

Avadel Pharmaceuticals Debt to Assets

Balance Sheet >

Avadel Pharmaceuticals Cash Flow

Cash Flow >

Avadel Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing